Eli Lilly declares USD 1.73 dividend for Eli Lilly stock
Published on 10/28/2026 at 11:50 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSDividend and earnings setup
- Eli Lilly declared a USD 1.73 per-share dividend on October 26, 2026.
- Second-quarter 2026 revenue reached USD 22.97 billion, alongside USD 7.10 billion in net income.
- Eli Lilly stock trades at EUR 1,143.30 at 11:45 a.m. CEST at Lang & Schwarz on October 28, 2026, 0.50 percent below the Xetra close of October 27, 2026.
- Market capitalization stood at USD 1.1 trillion on October 28, 2026.
Eli Lilly and Co. (ISIN US5324571083) declared a USD 1.73 per-share dividend for the fourth quarter of 2026 on October 26, 2026. The Eli Lilly and Company release says the payment is scheduled for December 10, 2026, for shareholders of record at the close of business on November 13, 2026.
What does the dividend signal?
The declaration gives investors a defined cash distribution while attention shifts to Lilly's third-quarter results. The company reported USD 22.97 billion of revenue and USD 7.10 billion of net income attributable to common shareholders for the second quarter of 2026, with diluted earnings per share of USD 7.94.
The dividend announcement also arrives after a busy October for Lilly. On October 22, 2026, the company announced a new USD 5.00 billion manufacturing facility in Virginia, while its October 24 oncology release reported a 79.00 percent confirmed objective response rate and a 100.00 percent disease control rate for an investigational treatment combination. Those developments broaden the near-term investor narrative beyond the company's established diabetes and obesity franchises.
When are the next cash dates?
The two dates attached to the dividend are November 13, 2026, when the shareholder record is set, and December 10, 2026, when payment is scheduled. The declared amount is a cash distribution, not a change to the company's earnings outlook.
Stock remains below its October high
At Lang & Schwarz, the stock was trading at EUR 1,143.30 on October 28, 2026, at 11:45 a.m. CEST, down 0.50 percent versus the Xetra close of October 27, 2026, at EUR 1,149.00. The finance quote showed a primary-market range of USD 697.70 to USD 1,175.80 and market capitalization of USD 1.1 trillion as of October 28, 2026. Eli Lilly is listed on the NYSE under LLY.
The further course of trading is shown by the continuously updated real-time quote of Eli Lilly stock.
Eli Lilly stock facts
- Company: Eli Lilly and Company
- ISIN: US5324571083
- Ticker: LLY
- Primary exchange: NYSE
- Price Lang & Schwarz (as of October 28, 2026, 11:45 a.m. CEST): EUR 1,143.30
- Change versus Xetra close: minus 0.50 percent
- Xetra close (October 27, 2026): EUR 1,149.00
- Market capitalization: USD 1.1 trillion (as of October 28, 2026)
- 52-week range: USD 697.70-1,175.80 (as of October 28, 2026)
- Sector / Industry: Healthcare / Drug Manufacturers - General
Market context: Market report S&P 500.
